Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bendele

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 11, 2011
Magnetic excitations of Fe(1+y)Se(x)Te(1-x) in magnetic and superconductive phasesP Babkevich, M Bendele, A T Boothroyd, et al.
Experimental Hematology|May 18, 2004
Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion proteinGeorge N Cox, Darin J Smith, Sharon J Carlson, et al.
Clinical and Experimental Rheumatology|November 2, 1999
Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 17, 2011
Synthesis and crystal growth of Cs(0.8)(FeSe(0.98))(2): a new iron-based superconductor with T(c) = 27 KA Krzton-Maziopa, Z Shermadini, E Pomjakushina, et al.
Osteoarthritis and Cartilage|May 18, 2005
Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritisE E Moore, A M Bendele, D L Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389A M Bendele, K J Ruterbories, S M Spaethe, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 24, 1999
Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Physical Review Letters|April 7, 2010
Pressure induced static magnetic order in superconducting FeSe1-xM Bendele, A Amato, K Conder, et al.
Immunopharmacology and Immunotoxicology|January 1, 1989
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic interventionL D Butler, K M Mohler, N K Layman, et al.
Advanced Drug Delivery Reviews|September 23, 2003
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseasesCarl K Edwards, Steven W Martin, James Seely, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 11, 2011
Magnetic excitations of Fe(1+y)Se(x)Te(1-x) in magnetic and superconductive phasesP Babkevich, M Bendele, A T Boothroyd, et al.
Experimental Hematology|May 18, 2004
Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion proteinGeorge N Cox, Darin J Smith, Sharon J Carlson, et al.
Clinical and Experimental Rheumatology|November 2, 1999
Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 17, 2011
Synthesis and crystal growth of Cs(0.8)(FeSe(0.98))(2): a new iron-based superconductor with T(c) = 27 KA Krzton-Maziopa, Z Shermadini, E Pomjakushina, et al.
Osteoarthritis and Cartilage|May 18, 2005
Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritisE E Moore, A M Bendele, D L Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389A M Bendele, K J Ruterbories, S M Spaethe, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 24, 1999
Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Physical Review Letters|April 7, 2010
Pressure induced static magnetic order in superconducting FeSe1-xM Bendele, A Amato, K Conder, et al.
Immunopharmacology and Immunotoxicology|January 1, 1989
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic interventionL D Butler, K M Mohler, N K Layman, et al.
Advanced Drug Delivery Reviews|September 23, 2003
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseasesCarl K Edwards, Steven W Martin, James Seely, et al.
Pageof 9